26-09-2020
Covid-19

Scientists can identified that highly effective antibodies against the novel coronavirus , when they say can lead to the development of a passive vaccination of covid-19 . Passive vaccination involves the administration of readymade antibodies which are degraded after sometime.

However the effect of passive vaccination is almost immediate , whereas an active vaccination it has to build up first , the researchers said. Some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects.

The scientists at the German Center for Neurodegenerative Diseases (DZNE) and Charite - Universitatsmedizin Berlin isolated almost 600 different antibodies from the blood of individuals who had overcome Covid-19, the disease triggered by Sars-Cov2